Cisplatin or Doxorubicin Reduces Cell Viability via the PTPIVA3-JAK2-STAT3 Cascade in Hepatocellular Carcinoma

Cisplatin or Doxorubicin Reduces Cell Viability via the PTPIVA3-JAK2-STAT3 Cascade in Hepatocellular Carcinoma

Chao-Jen Li,1,* Hung-Wen Tsai,2,* Yi-Li Chen,3 Chun-I Wang,4 Yang-Hsiang Lin,5 Pei-Ming Chu,6,7 Hsiang-Cheng Chi,8,9 Yi-Ching Huang,3 Cheng-Yi Chen3 1Department of General & Gastroenterological Surgery, An Nan Hospital, China Medical University, Tainan, Taiwan; 2Department of Pat...

Full description

Bibliographic Details
Main Authors: Li CJ, Tsai HW, Chen YL, Wang CI, Lin YH, Chu PM, Chi HC, Huang YC, Chen CY
Format: Article
Language:English
Published: Dove Medical Press 2023-01-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
hepatocellular carcinoma
chemoresistance
cisplatin
doxorubicin
ptp4a3
il-6
Online Access:https://www.dovepress.com/cisplatin-or-doxorubicin-reduces-cell-viability-via-the-ptpiva3-jak2-s-peer-reviewed-fulltext-article-JHC

Similar Items

Similar Items